You are here: Industry Insights > Covaxin

News List

Covaxin receives GMP certificate from Hungarian authorities expresspharma
August 06, 2021
Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech said in a statement.
Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: Minister expresspharma
August 05, 2021
The monthly production capacity of Covishield is projected to be increased to more than 120 million doses, and of Covaxin to around 58 million doses by December, the government told Rajya Sabha August 3, citing information from the COVID-19 vaccine ...
After suspending EUA request, Brazil now shelves import authorisation of Covaxin expresspharma
July 30, 2021
After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin and a request for Emergency Use Authorisation, Brazil now has suspended its decision to import four million doses of the jab into that country.
Only marginal difference in purchase price of Covishield and Covaxin for Centre: MoS Health expresspharma
July 27, 2021
The Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries as recommended by NEGVAC.
Centre to buy Covishield and Covaxin at revised rates expresspharma
July 20, 2021
The price of each dose of Covishield amounts to Rs 215.25, and Covaxin Rs 225.75, including taxes.
Ocugen seeks approval for Covaxin in Canada expresspharma
July 19, 2021
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said.
Ocugen commences rolling submission of COVAXIN to Health Canada pharmaceutical-technology
July 16, 2021
Ocugen has commenced the rolling submission to Health Canada for its Covid-19 vaccine candidate, COVAXIN, which is being jointly developed with Bharat Biotech International for use in the US and Canada.
Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech firstwordpharma
July 13, 2021
Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing of its COVID-19 vaccine Covaxin to the World Health Organization (WHO), as reported by The Economic Times.
WHO is likely to decide on EUL of Covaxin in four to six weeks expresspharma
July 12, 2021
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.
Striving to increase vaccine availability through imports: Govt expresspharma
July 09, 2021
MEA Spokesperson Arindam Bagchi said India hopes that individual countries would increasingly recognise made-in-India vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page